Mark Your Calendar: These 4 Pharma Stocks Are Prepping For The Big Day

The following are some of the companies that are slated to report phase III trial results in the coming weeks. Do you have these stocks in your portfolio?

from RTT - Biotech http://bit.ly/2WX3sgp
via IFTTT